Health Updates Webinar #181 “Mare, Anong Latest na Kontra Diabetes?” New Meds on the Block

The University of the Philippines
in partnership with the UP Manila – National Institutes of Health
and in cooperation with UP Philippine General Hospital and UP College of Medicine
would like to invite you to attend this webinar!

Registration slots are limited to this SPECIAL EDITION of
HEALTH UPDATES
So sign up NOW:
bit.ly/HealthUpdatesWebinar181

Webinar #181
February 23, 2024 (Friday) 12nn
“Mare, Anong Latest na Kontra Diabetes”
New Meds on the Block

Presenter:
DR. JOY ARABELLE C. FONTANILLA
Chief, Section on Endocrinology, Diabetes, and Metabolism
Asian Hospital and Medical Center

Reactor:
DR. MARIA PATRICIA DEANNA C. MANINGAT
Chief, Center for Diabetes, Thyroid, and Endocrine Disorders
St. Luke’s Medical Center – Global City

———————————————————–

Webinar #181
February 23, 2024 (Friday) 12nn
“Mare, Anong Latest na Kontra Diabetes”
New Meds on the Block

In this webinar, we will elucidate the intricacies of the latest diabetes medications, delving into pharmacological mechanisms, molecular targets, and clinical outcomes. From novel incretin-based therapies to advancements in SGLT-2 inhibitors, we will aim to provide an in-depth exploration of the evolving pharmacotherapeutic landscape. Our esteemed speakers will share their insights and expertise on the latest developments in diabetes medications, shedding light on novel approaches that promise to revolutionize diabetes management. From cutting-edge pharmaceuticals to emerging therapeutic strategies, our experts will delve into the nuances of these innovations and their potential impact on patient care.

Our main presenter is Dr. Joy Arabelle C. Fontanilla, who is the Chief of the Section of Endocrinology, Diabetes, and Metabolism at the Asian Hospital and Medical Center. Our reactor is Dr. Maria Patricia Deanna D. Maningat, who is the Chief of the Center for Diabetes, Thyroid, and Endocrine Disorders at the St. Luke’s Medical Center – Global City.

Join us as we bring together experts, researchers, and advocates to gain a comprehensive insight into the forefront of diabetes pharmacotherapy. Together, let us advance our collective understanding of diabetes and contribute to the improvement of patient outcomes.

Together, we can stop preventable deaths!